X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (23) 23
index medicus (22) 22
metallurgy (22) 22
organic chemistry (20) 20
humans (18) 18
human necessities (14) 14
hygiene (14) 14
medical or veterinary science (14) 14
peptides (14) 14
preparations for medical, dental, or toilet purposes (14) 14
female (13) 13
male (12) 12
specific therapeutic activity of chemical compounds ormedicinal preparations (12) 12
microbiology (11) 11
aged (9) 9
biochemistry (9) 9
aged, 80 and over (8) 8
alzheimer's disease (8) 8
beer (8) 8
compositions or test papers therefor (8) 8
condition-responsive control in microbiological orenzymological processes (8) 8
enzymology (8) 8
measuring or testing processes involving enzymes, nucleicacids or microorganisms (8) 8
mutation or genetic engineering (8) 8
neurosciences (8) 8
processes of preparing such compositions (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
middle aged (7) 7
alzheimer disease - pathology (6) 6
dementia (6) 6
derivatives thereof (6) 6
mri (6) 6
neurology (6) 6
nucleic acids (6) 6
nucleosides (6) 6
nucleotides (6) 6
sugars (6) 6
alzheimers disease (5) 5
article (5) 5
atrophy (5) 5
biomarkers (5) 5
neuroimaging (5) 5
reproducibility of results (5) 5
adult (4) 4
brain (4) 4
clinical neurology (4) 4
internal medicine (4) 4
magnetic resonance imaging (4) 4
radiology, nuclear medicine & medical imaging (4) 4
sensitivity and specificity (4) 4
viral load (4) 4
virology (4) 4
adolescent (3) 3
algorithms (3) 3
alzheimer disease - genetics (3) 3
alzheimer disease - psychology (3) 3
brain - pathology (3) 3
brain mapping (3) 3
cerebrospinal fluid (3) 3
databases, factual (3) 3
decline (3) 3
diagnostic imaging (3) 3
disease progression (3) 3
hepacivirus - genetics (3) 3
hepacivirus - isolation & purification (3) 3
longitudinal studies (3) 3
medical research (3) 3
mild cognitive impairment (3) 3
neurodegenerative diseases (3) 3
neuropsychological tests (3) 3
pathology (3) 3
performance (3) 3
pharmaceutical industry (3) 3
psychiatry (3) 3
reagent kits, diagnostic (3) 3
rna (3) 3
studies (3) 3
tau protein (3) 3
80 and over (2) 2
a-beta (2) 2
abridged index medicus (2) 2
aging (2) 2
alzheimer disease (2) 2
alzheimer disease - cerebrospinal fluid (2) 2
alzheimer disease - classification (2) 2
alzheimer disease - diagnosis (2) 2
alzheimers-disease (2) 2
alzheimer’s disease (2) 2
amyloid (2) 2
amyloid beta-peptides - cerebrospinal fluid (2) 2
amyloid beta-peptides - metabolism (2) 2
amyloid beta-protein (2) 2
amyloid-beta (2) 2
angiogenesis (2) 2
animals (2) 2
antibodies (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52) 52
French (9) 9
German (7) 7
Chinese (3) 3
Spanish (3) 3
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 11/2009, Volume 15, Issue 21, pp. 6674 - 6682
Journal Article
NeuroImage, ISSN 1053-8119, 02/2012, Volume 59, Issue 3, pp. 2362 - 2373
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 07/2012, Volume 32, Issue 28, pp. 9677 - 9689
Passive immunization against beta-amyloid (A beta) has become an increasingly desirable strategy as a therapeutic treatment for Alzheimer's disease (AD).... 
APP TRANSGENIC MICE | NATURAL OLIGOMERS | HUMAN IGG1 | ALZHEIMERS-DISEASE | PROTEIN-KINASE | LONG-TERM POTENTIATION | SYNAPTIC PLASTICITY | NEUROSCIENCES | PASSIVE-IMMUNIZATION | SECRETED OLIGOMERS | P38 MAP KINASE | Microglia - metabolism | Humans | Middle Aged | Male | Green Fluorescent Proteins - genetics | Neuroprotective Agents - metabolism | Alzheimer Disease - pathology | Neuroprotective Agents - pharmacology | Time Factors | Protein Binding - drug effects | Amyloid beta-Peptides - metabolism | Statistics, Nonparametric | Aged, 80 and over | Neurons - metabolism | p38 Mitogen-Activated Protein Kinases - metabolism | Alzheimer Disease - immunology | Receptors, Chemokine - genetics | Plaque, Amyloid - immunology | Disease Models, Animal | Animals, Newborn | Rats | Mice, Transgenic | Mutation - genetics | Rats, Sprague-Dawley | Microscopy, Confocal | Plaque, Amyloid - metabolism | Mice | CX3C Chemokine Receptor 1 | Alzheimer Disease - blood | Immunoglobulin G - metabolism | Tumor Necrosis Factor-alpha - metabolism | Dose-Response Relationship, Immunologic | Cerebral Cortex - cytology | Dose-Response Relationship, Drug | Immunoglobulin G - pharmacology | Female | Neurons - drug effects | Peptide Fragments - metabolism | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Microglia - drug effects | Plaque, Amyloid - pathology | Gene Expression Regulation - genetics | Gene Expression Regulation - immunology | Alzheimer Disease - therapy | Cells, Cultured | Presenilin-1 - genetics | Hippocampus - cytology | Gene Expression Regulation - drug effects | Amyloid beta-Protein Precursor - genetics | Animals | Amyloid beta-Peptides - immunology | Aged | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 04/2018, Volume 90, Issue 21, pp. E1889 - E1897
OBJECTIVETo evaluate the safety and efficacy of crenezumab in patients with mild to moderate Alzheimer disease (AD). METHODSIn this phase 2 trial, 431 patients... 
DEMENTIA | CLINICAL-TRIALS | A-BETA | NEURODEGENERATION | ANTIBODY | BAPINEUZUMAB | ASSESSMENT SCALE | PNEUMONIA | OLIGOMERS | CLINICAL NEUROLOGY | 322
Journal Article
NeuroImage, ISSN 1053-8119, 02/2012, Volume 59, Issue 3, pp. 2217 - 2230
Journal Article
by Tosun, Duygu and Schuff, Norbert and Mathis, Chester A and Jagust, William and Weiner, Michael W and Saradha, A and Abdi, Herve and Abdulkadir, Ahmed and Abeliovich, Asa and Abellan van Kan, Gabor and Abner, Erin and Acharya, Deepa and Agrusti, Antonella and Agyemang, Alex and Ahdidan, Jamila and Ahmed, Shiek and Ahn, Jae Eun and Aisen, Paul and Aksu, Yaman and Al-Akhras, Mousa and Alarcon, Marcelo and Alberca, Roman and Alexander, Gene and Alexander, Daniel and Alin, Aylin and Almeida, Fabio and Amlien, Inge and Anand, Shyam and Anderson, Dallas and Anew, Marilee and Angersbach, Steve and Anjum, Ayesha and Aoyama, Eiji and Arfanakis, Konstantinos and Armor, Tom and Arnold, Steven and Arunagiri, Vidhya and Asatryan, Albert and Ashe-McNalley, Cody and Ashiga, Hirokazu and Assareh, Arezoo and Le Page, Aurelie and Avants, Brian and Avinash, Gopal and Aviv, Richard and Awasthi, Sukrati and Ayan-Oshodi, Mosun and Babic, Tomislav and Baek, Young and Bagci, Ulas and Bai, Shuyang and Baird, Geoffrey and Baker, John and Banks, Sarah and Bard, Jonathan and Barnes, Josephine and Bartlett, Jonathan and Bartzokis, George and Barua, Neil and Bauer, Corinna and Bayley, Peter and Beck, Irene and Becker, James and Becker, J. Alex and Beckett, Laurel and Bednar, Martin and Beg, Mirza Faisal and Bek, Stephan and Belaroussi, Boubakeur and Belmokhtar, Nabil and Bernard, Charlotte and Bertram, Lars and Bhaskar, Uday and Biffi, Alessano and Bigler, Erin and Bilgic, Basar and Bishop, Courtney and Bittner, Daniel and Black, Ronald and Bogorodzki, Piotr and Bokde, Arun and Bonner-Jackson, Aaron and Boppana, Madhu and Bourgeat, Pierrick and Bowes, Mike and Bowman, DuBois and Bowman, Gene and Braskie, Meredith and Braunewell, Karl and Breitner, Joihn and Bresell, Anders and Brewer, James and Brickman, Adam and Britschgi, Markus and Broadbent, Steve and Brogren, Jacob and Brooks, David and Browndyke, Jeffrey and Brunton, Simon and Buchert, Ralph and ... and Alzheimer's Dis NeuroImaging Initi and Alzheimer's Disease NeuroImaging Initiative
Brain, ISSN 0006-8950, 2011, Volume 134, Issue Part 4, pp. 1077 - 1088
Journal Article